AbbVie results beat expectations despite low-cost competition to blockbuster Humira
October 27, 2023 at 07:42 AM EDT
Drugmaker raises its full-year earnings outlook, boosts 2024 dividend 4.7%
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|